Brief: Citius Pharmaceuticals Announces Nomination Of Pharmaceutical Executive Robert J. Smith To Its Board Of Directors
23/01/2024 15:13
Jan 23 (Reuters) - Citius Pharmaceuticals Inc CTXR.O :
* CITIUS PHARMACEUTICALS ANNOUNCES NOMINATION OF
PHARMACEUTICAL
EXECUTIVE ROBERT J. SMITH TO ITS BOARD OF DIRECTORS
* CITIUS PHARMACEUTICALS INC -UPON APPROVAL, CITIUS BOARD OF
DIRECTORS WILL CONSIST OF SEVEN MEMBERS
Source text for Eikon: ID:nPn5XRxVqa
Further company coverage: CTXR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules